About TACROLIMU S 0.03%W/W
Topical calcineurin inhibitor immunosuppressant
Used for
- Treats moderate-to-severe atopic dermatitis (eczema), including in children.
Usual adult dose
Apply a thin layer twice daily until eczema clears; use the lowest effective amount.
Usual dose in children
For children aged 2–15 years: apply a thin layer twice daily until eczema clears.
Common side effects
- Burning, stinging, or itching at the application site
- Skin redness or irritation
- Increased sensitivity to sunlight
- Skin infections, including cold sores or chickenpox
Important warnings
- For skin use only; avoid eyes, mouth, and infected skin.
- Avoid ultraviolet light, tanning beds, and phototherapy.
- Not for children under 2 years; long-term safety is uncertain.
- Rare reports of lymphoma and skin cancer; a causal link is unproven.
Pregnancy
Use only if clearly needed; discuss potential risks with a healthcare professional.
Breastfeeding
Avoid applying to the breast; discuss use with a healthcare professional.
Interactions
- Other immunosuppressant medicines may increase immune suppression.
- Avoid live vaccines during treatment when possible; response may be reduced.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.